评估增强T1 mapping MR成像在评估子宫内膜癌肌层浸润深度和检测DNA错配修复状态中的效用:一项先导研究
这项前瞻性先导研究纳入46例病理确诊的子宫内膜癌患者,比较T2WI+DWI+增强T1 mapping与T2WI+DWI+DCE评估肌层浸润深度的诊断效能,并分析天然T1值检测错配修复状态的价值;增强T1 mapping方案诊断准确率数值更高但差异无统计学意义,观察者间一致性提高,天然T1值在错配修复缺陷组较低。
要点
- 增强T1 mapping联合T2WI和DWI评估肌层浸润深度的诊断准确率数值上高于联合DCE,但差异无统计学意义。
- 加入增强T1 mapping后观察者间一致性提高, junior readers的κ值从0.538升至0.898。
- 天然T1值在错配修复缺陷组较低,鉴别缺陷与 proficient 的AUC为0.729, cutoff 1524.7 ms时敏感度87.0%、特异度67.7%。
核心结论
- 增强T1 mapping纳入常规MR方案后评估子宫内膜癌肌层浸润深度的诊断效能与DCE相当,并显著提高观察者间一致性;天然T1值有潜力作为检测错配修复状态的无创生物标志物。
研究设计与样本
- 前瞻性先导研究,纳入46例病理确诊的子宫内膜癌患者,均在两周内接受盆腔MRI和手术;每位患者行多参数MRI包括T2WI、DWI、DCE、天然T1 mapping和增强T1 mapping;由四名放射科医师(两名初级、两名高级)独立评估;以组织病理学为参考标准,错配修复状态由免疫组化确定。
关键影像表现/征象
- 增强T1 mapping联合T2WI和DWI评估肌层浸润深度的诊断准确率在所有读者中均高于联合DCE,尤其在初级放射科医师中,但差异无统计学意义(P > 0.05)。
- 加入增强T1 mapping后观察者间一致性提高,尤其对初级读者(κ = 0.898 vs. κ = 0.538)。
- 天然T1值在错配修复 proficient 组显著高于错配修复缺陷组(1655.5 ± 131.9 ms vs. 1549.1 ± 125.9 ms,P = 0.047)。
诊断标准与关键数值
- 增强T1 mapping联合方案评估肌层浸润深度的诊断准确率数值高于DCE联合方案,但差异无统计学意义(P > 0.05)。
- 天然T1值鉴别错配修复缺陷与 proficient 的AUC为0.729, cutoff 1524.7 ms时敏感度87.0%、特异度67.7%。
- 观察者间一致性κ值:增强T1 mapping方案为0.898,DCE方案为0.538(原文表述为 junior readers 的对比)。
临床应用与阅片要点
- 增强T1 mapping可纳入常规MR协议,用于评估子宫内膜癌肌层浸润深度,诊断效能与DCE相当。
- 增强T1 mapping有助于提高观察者间一致性,尤其对初级放射科医师。
- 天然T1值可作为检测错配修复状态的无创影像生物标志物, cutoff 值为1524.7 ms。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the value of enhanced T1 mapping MR imaging in assessing the depth of myometrial invasion (MI) and in detecting DNA mismatch repair (MMR) status in endometrial cancer (EC) as a non-invasive imaging biomarker.
METHODS: This prospective study enrolled 46 patients with pathologically confirmed EC who underwent pelvic MRI and surgery within two weeks. Each patient underwent multiparametric MRI including T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), dynamic contrast-enhanced imaging (DCE), native T1 mapping and enhanced T1 mapping. Four radiologists (two junior, two senior) independently assessed MI depth of EC using two combinations: T2WI + DWI + DCE and T2WI + DWI + enhanced T1 mapping. Histopathology served as the reference standard. MMR status was determined by immunohistochemistry. Quantitative analysis of native T1, enhanced T1, and Apparent diffusion coefficient (ADC) values was performed, and inter-reader agreement and diagnostic performance were compared. Receiver operating characteristic curve (ROC) analysis was performed. Statistical significance was set at p < 0.05.
RESULTS: The diagnostic accuracy of T2WI + DWI + enhanced T1 mapping for assessing MI was higher than that of T2WI + DWI + DCE across all readers, especially among junior radiologists, though differences were not statistically significant (P > 0.05). Inter-reader agreement improved with enhanced T1 mapping, particularly for junior readers (κ = 0.898 vs. κ = 0.538). Native T1 values were significantly higher in the proficient MMR group compared to the deficient MMR group (1655.5 ± 131.9 ms vs. 1549.1 ± 125.9 ms, P = 0.047). ROC analysis yielded an Area under the curve (AUC) of 0.729 for differentiating deficient MMR from proficient MMR, with a sensitivity of 87.0% and specificity of 67.7% at a cutoff of 1524.7 ms.
CONCLUSION: Enhanced T1 mapping, when incorporated into routine MR protocols, offers diagnostic performance comparable to DCE for evaluating myometrial invasion in endometrial cancer and significantly improves inter-reader agreement. Native T1 values show promise as a non-invasive biomarker for detecting MMR status in EC.
引用
- Liu XY, Yuan ZL, Yang SY, et al. Evaluating the utility of enhanced T1 mapping MR imaging in assessing depth of myometrial invasion and detecting DNA mismatch repair status in endometrial cancer: a pilot study. Abdom Radiol (NY). 2025. PMID: 40828400. doi:10.1007/s00261-025-05173-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。